Key Inflammatory Biomarkers in Perinatal Asphyxia: A Comprehensive Review
Lynn Bitar1, Barbara S Stonestreet2, Lina F Chalak1
1Division of Neonatal-Perinatal Medicine, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX 75235, USA.
Insights
Inflammatory biomarkers show promise in predicting the severity and outcomes of hypoxic-ischemia encephalopathy (HIE). Further research is needed to optimize their use in clinical decision-making for newborns with HIE.
Area of Science:
- Neonatal Medicine
- Biomarker Research
- Neurodevelopmental Pediatrics
Background:
- Hypoxic-ischemia encephalopathy (HIE) is a serious condition in newborns resulting from oxygen deprivation.
- Early identification and management of HIE are crucial for improving neurodevelopmental outcomes.
- Inflammatory processes play a significant role in the pathophysiology and progression of HIE.
Purpose of the Study:
- To summarize current evidence on placental and postnatal inflammatory biomarkers in HIE.
- To evaluate the diagnostic accuracy of these biomarkers for predicting HIE severity.
- To assess their utility in monitoring treatment response and predicting neurodevelopmental outcomes.
Main Methods:
- Systematic review of existing literature on inflammatory biomarkers and HIE.
- Analysis of studies reporting on diagnostic accuracy, treatment response assessment, and outcome prediction.
- Synthesis of findings related to both short- and long-term neurodevelopmental trajectories.
Main Results:
- Inflammatory biomarkers demonstrate potential in predicting HIE severity.
- Evidence suggests their value in assessing response to therapeutic interventions.
- Biomarkers may offer predictive insights into short- and long-term neurodevelopmental outcomes.
Conclusions:
- Inflammatory biomarkers can guide clinical decisions during the critical early stages of perinatal asphyxia.
- Additional research is essential to fully understand and optimize the utility of biomarkers for HIE management.
- Further investigation is needed to refine predictive models for HIE severity, evolution, and developmental outcomes.
Abstract:
This article summarizes the current evidence regarding inflammatory biomarkers (placental and postnatal) and provides a comprehensive understanding of their roles: (1) diagnostic accuracy to predict the severity of hypoxic-ischemia encephalopathy (HIE), (2) value in assessing treatment responses, and (3) prediction of both short- and long-term neurodevelopmental outcomes. In the early critical stages of perinatal asphyxia, inflammatory biomarkers may guide clinical decision-making. Additional research is required to increase our understanding of the optimal utility of biomarkers to predict the severity, evolution, and developmental outcomes after exposure to HIE.
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...